Cision PR Newswire

AccidentAccidentAir PollutionAll NewsAnnoucementArgricultureArtASEANBook

Pigeon Showcases Parenting Innovations at CIIE 2026 Under “Boundless Joy of Newborn” Theme

SHANGHAI, Nov. 7, 2026 /PRNewswire/ -- Pigeon, a global leader in baby feeding and care, returned to the China International Import Expo (CIIE) for the fourth consecutive year, showcasing baby care products and research innovations from around the world, together with its latest achievements in product development, smart manufacturing,...

Indonesian Students Achieve Success at The Hong Kong Polytechnic University

Join Our Event at the Pullman Jakarta Central Park on 23 March 2025 HONG KONG, March 10, 2025 /PRNewswire/ -- Choosing the right...

Next-Gen ProAV: Hikvision rolls out an evolving audio-visual ecosystem with digital innovations at ISLE 2025

HANGZHOU, China, March 10, 2025 /PRNewswire/ -- As an innovative industry pioneer, Hikvision has elevated ProAV by showcasing immersive experiences at ISLE 2025. This...

CrowdStrike Awarded with Frost & Sullivan’s 2024 Company of the Year Award for SaaS Security Posture Management Leadership

CrowdStrike Falcon® Shield delivers industry-leading protection and control over SaaS misconfigurations, identities and threats – unifying hybrid identity protection SAN ANTONIO, March 10,...

Plus and TIER IV Partner to Advance Autonomy 2.0 in Japan, Starting with Driverless Trucks

TOKYO...

Ubiqconn Joins Satellite 2025 to Showcase Cutting-Edge Satellite Communication Solutions

TAIPEI,...

Kelun-Biotech’s TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) Approved for Marketing in Second Indication by NMPA for EGFRm NSCLC

CHENGDU, China, March 10, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT,...
1...3,9963,9973,998...4,510Page 3,997 of 4,510